We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$32.9B
AUM Growth
-$855M
Cap. Flow
-$1.68B
Cap. Flow %
-5.1%
Top 10 Hldgs %
29.62%
Holding
1,163
New
73
Increased
397
Reduced
461
Closed
98

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$87.5M
2
SHW icon
Sherwin-Williams
SHW
+$76.1M
3
HD icon
Home Depot
HD
+$68M
4
LIN icon
Linde
LIN
+$55M
5
BMY icon
Bristol-Myers Squibb
BMY
+$50.3M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$95.3M
2
AAPL icon
Apple
AAPL
+$83.2M
3
AVGO icon
Broadcom
AVGO
+$76.2M
4
ELV icon
Elevance Health
ELV
+$71.4M
5
NVDA icon
NVIDIA
NVDA
+$69.2M

Sector Composition

Rank Sector Weight
1 Technology 37.44%
2 Healthcare 14.27%
3 Consumer Discretionary 12.23%
4 Financials 8.85%
5 Industrials 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
F icon
676
Ford
F
$53.8B
$2.61M 0.01%
264,057
-94,511
-26% -$1.01M
GEHC icon
677
GE HealthCare
GEHC
$29B
$2.61M 0.01%
33,370
-18,943
-36% -$1.61M
SCS
678
DELISTED
Steelcase
SCS
$2.58M 0.01%
218,336
+103,236
+90% +$1.33M
ADEA icon
679
Adeia
ADEA
$2.75B
$2.58M 0.01%
184,353
+18,819
+11% +$238K
AFG icon
680
American Financial Group
AFG
$11.9B
$2.56M 0.01%
18,672
-28,171
-60% -$3.88M
BLMN icon
681
Bloomin' Brands
BLMN
$691M
$2.5M 0.01%
204,739
+20,689
+11% +$297K
VCYT icon
682
Veracyte
VCYT
$3.17B
$2.5M 0.01%
63,103
-61,999
-50% -$2.35M
HUM icon
683
Humana
HUM
$47.4B
$2.49M 0.01%
9,797
-2,903
-23% -$779K
LGF.A
684
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$2.48M 0.01%
290,506
EMBC icon
685
Embecta
EMBC
$288M
$2.48M 0.01%
120,138
-7,457
-6% -$122K
UNIT
686
Uniti Group
UNIT
$2.34B
$2.47M 0.01%
449,646
IART icon
687
Integra LifeSciences
IART
$1.22B
$2.47M 0.01%
109,004
+10,543
+11% +$230K
CINF icon
688
Cincinnati Financial
CINF
$26.3B
$2.46M 0.01%
17,147
+13,236
+338% +$1.93M
IMVT icon
689
Immunovant
IMVT
$7.5B
$2.44M 0.01%
98,683
-155
-0.2% -$4.4K
TME icon
690
Tencent Music
TME
$12.9B
$2.44M 0.01%
215,339
BURL icon
691
Burlington
BURL
$14.3B
$2.43M 0.01%
8,529
+4,182
+96% +$1.13M
KEYS icon
692
Keysight
KEYS
$53.3B
$2.42M 0.01%
15,067
-6,928
-31% -$1.12M
ROL icon
693
Rollins
ROL
$16.3B
$2.39M 0.01%
51,615
-41,347
-44% -$2.02M
SIG icon
694
Signet Jewelers
SIG
$3.82B
$2.39M 0.01%
29,639
-19,974
-40% -$1.86M
ESS icon
695
Essex Property Trust
ESS
$17.7B
$2.38M 0.01%
8,338
-7,079
-46% -$2.09M
HAS icon
696
Hasbro
HAS
$12.7B
$2.37M 0.01%
42,413
+829
+2% +$54.1K
WEX icon
697
WEX
WEX
$6.87B
$2.33M 0.01%
13,291
-8,121
-38% -$1.52M
IESC icon
698
IES Holdings
IESC
$12.4B
$2.33M 0.01%
+23,164
New +$2.78M
MD icon
699
Pediatrix Medical
MD
$2.16B
$2.31M 0.01%
176,040
NXST icon
700
Nexstar Media Group
NXST
$5.18B
$2.3M 0.01%
14,584
+1,405
+11% +$236K

Similar funds

Axa's Q4 2024 Portfolio in Review

As of Q4 2024, Axa held 1,163 positions worth $32.9B, down 2.5% from $33.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Axa withdrew a net $1.68B in Q4 2024, closing 98 positions and reducing 461 holdings. Its most notable exit was Altair Engineering Inc, an estimated $67.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Axa opened a new position in JBT Marel worth $34.4M.

  • Axa's largest Q4 2024 buy was JBT Marel: 270,829 shares worth $34.4M.
  • Axa added most to Salesforce in Q4 2024, an estimated $87.5M increase.
  • Axa's biggest Q4 2024 reduction was Advanced Micro Devices, cutting an estimated $95.3M.
  • Axa fully exited Altair Engineering Inc in Q4 2024, selling an estimated $67.5M.
  • Axa's ten largest holdings make up 30% of its $32.9B portfolio in Q4 2024.
  • Axa opened 73 new positions and closed 98 in Q4 2024.
  • Axa's portfolio value fell 2.5% quarter-over-quarter to $32.9B.

Based on Axa's 13F filing for Q4 2024, filed 14 Feb 2025.